Skip to main content

Table 1 Clinical characteristics of subjects participating in study I and II

From: Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation

  Study I Study II
Healthy (n = 5) Controla (n = 14) Asthma + CRS (n = 15) Asthma only (n = 13)
Sex (M/F) 0/5 5/9 4/11 3/10
Age (years) 41 ± 7 40 ± 3 38 ± 3 44 ± 3
Body mass index 25.2 ± 1.2 24.4 ± 0.5 25.5 ± 0.9 27.4 ± 1.4
FEV1 (% predicted) 111 ± 6 101 ± 4 96 ± 4 93 ± 4
FeNO (ppb) 12 ± 1 15 ± 2 15 ± 5 19 ± 3
SPT (neg/pos) 3/1b 10/3b 4/11 2/11
  1. Where appropriate, data are expressed as mean ± SEM
  2. All subject included had withdrawn from antihistamines for 72 h, long acting beta agonist (LABA) for 24 h and short acting beta agonist (SABA) for 8 h and Spiriva for 24 h prior to sample collection
  3. M male; F female; FEV 1 forced expiratory volume in 1 s; FeNO fractional exhaled nitric oxide; SPT skin prick test
  4. aThe subjects in study I are also included in study II as controls
  5. bOne value missing